bosentan anhydrous has been researched along with Kidney Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, J; Kaur, T; Pathak, D; Sharma, AK; Singh, AP; Singh, B; Yadav, HN | 1 |
| Akita, K; Isobe, S; Isoda, K; Iwakura, Y; Minamino, T; Niida, T; Ohtomo, F; Sano, M; Sato-Okabayashi, Y; Shimada, K | 1 |
| Belloni, AS; Buccella, V; Calò, LA; Caroccia, B; Gioco, F; Guerzoni, E; Guidolin, D; Montini, B; Pagnin, E; Petrelli, L; Piazza, M; Ravarotto, V; Rossi, GP; Seccia, TM | 1 |
| Dingemanse, J; van Giersbergen, PL | 1 |
| Chen, YP; Dong, HR; Qiu, CB; Zhang, C | 1 |
| Gamberi, T; Gensini, GF; Mancia, G; Marchetta, M; Modesti, A; Modesti, PA; Morabito, M; Parati, G; Savia, G; Sofi, F; Vanni, S | 1 |
| Rubin, LJ | 1 |
| Benati, L; Benigni, A; Corna, D; Facchinetti, D; Orisio, S; Remuzzi, G; Zola, C | 1 |
| Aktan, AO; Bilsel, S; Moini, H; Sarac, AM; Scapa, E | 1 |
| Bernal, R; Blanco, J; Egido, J; Gomez-Garre, D; Gomez-Guerrero, C; Lopez-Franco, O; Ortega, L; Sugaya, T; Suzuki, Y; Tejera, N | 1 |
1 trial(s) available for bosentan anhydrous and Kidney Diseases
| Article | Year |
|---|---|
Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study.
Topics: Acute Disease; Adaptation, Physiological; Adult; Altitude; Altitude Sickness; Arginine Vasopressin; Bosentan; Creatinine; Diuresis; Double-Blind Method; Endothelin Receptor Antagonists; Endothelin-1; Female; Glomerular Filtration Rate; Humans; Hypertension, Pulmonary; Hypoxia; Kidney; Kidney Diseases; Male; Middle Aged; Muscle, Smooth, Vascular; Osmolar Concentration; Oxygen; Potassium Channels, Voltage-Gated; Pulmonary Artery; Pulmonary Edema; Receptors, Endothelin; Sulfonamides; Vasoconstriction | 2006 |
9 other study(ies) available for bosentan anhydrous and Kidney Diseases
| Article | Year |
|---|---|
Ameliorative role of bosentan, an endothelin receptor antagonist, against sodium arsenite-induced renal dysfunction in rats.
Topics: Animals; Arsenites; Bosentan; Endothelin Receptor Antagonists; Kidney Diseases; Oxidative Stress; Rats; Sodium Compounds | 2021 |
Blocking of interleukin-1 suppresses angiotensin II-induced renal injury.
Topics: Angiotensin II; Animals; Antibodies; Blood Pressure; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Fibrosis; Humans; Hypertension; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Kidney; Kidney Diseases; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction | 2021 |
Endothelin-1 Drives Epithelial-Mesenchymal Transition in Hypertensive Nephroangiosclerosis.
Topics: Actins; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Biphenyl Compounds; Bosentan; Cadherins; Endothelin B Receptor Antagonists; Endothelin-1; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Hypertension; Irbesartan; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Oligopeptides; Piperidines; Rats; Receptor, Endothelin B; rho-Associated Kinases; Signal Transduction; Sulfonamides; Tetrazoles | 2016 |
Influence of severe renal dysfunction on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist.
Topics: Adult; Antihypertensive Agents; Area Under Curve; Bosentan; Creatinine; Endothelin Receptor Antagonists; Humans; Kidney Diseases; Male; Middle Aged; Sulfonamides | 2002 |
[The therapeutic effects of bosentan and valsartan on renal interstitial fibrosis of chronic aristolochic acid nephropathy].
Topics: Animals; Aristolochic Acids; Bosentan; Collagen Type I; Connective Tissue Growth Factor; Disease Models, Animal; Fibrosis; Kidney; Kidney Diseases; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Sulfonamides; Tetrazoles; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1; Valine; Valsartan | 2005 |
Endothelin-1 and the pulmonary vascular response to altitude: a new therapeutic target?
Topics: Altitude; Altitude Sickness; Bosentan; Diuresis; Double-Blind Method; Endothelin Receptor Antagonists; Endothelin-1; Humans; Hypertension, Pulmonary; Hypoxia; Kidney Diseases; Muscle, Smooth, Vascular; Potassium Channels, Voltage-Gated; Randomized Controlled Trials as Topic; Receptors, Endothelin; Sulfonamides; Vasoconstriction; Ventricular Function, Right | 2006 |
Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney.
Topics: Analysis of Variance; Animals; Blotting, Northern; Bosentan; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Endothelin Receptor Antagonists; Gene Expression Regulation; Humans; Kidney; Kidney Diseases; Male; Nephrectomy; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Sulfonamides | 1996 |
Role of endothelin in obstructive jaundice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; beta-N-Acetylhexosaminidases; Bilirubin; Bosentan; Captopril; Cholestasis; Creatinine; Endothelin Receptor Antagonists; Endothelin-1; Hyaluronic Acid; Kidney Diseases; Liver; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Sulfonamides | 1999 |
Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bosentan; Endothelins; Extracellular Matrix; Isoquinolines; Kidney; Kidney Diseases; Kidney Tubules; Kinetics; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Proteinuria; Quinapril; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reference Values; RNA, Messenger; Serum Albumin, Bovine; Sulfonamides; Tetrahydroisoquinolines; Transcription Factor AP-1; Transforming Growth Factor beta | 2001 |